FAERS manufacturer drug profile
IMMUNE GLOBULIN INTRAVENOUS HUMAN · IMTIX SANGSTAT
FAERS manufacturer and drug safety profile
Key facts
| Drug | IMMUNE GLOBULIN INTRAVENOUS HUMAN |
|---|---|
| Manufacturer (report sender) | IMTIX SANGSTAT |
At a glance
- 10–99 FAERS reports from this manufacturer
- 1–9 Reports with hospitalization
- 10–99 Distinct reaction terms reported
- 10–99 Reactions flagged by Orca1 signal analytics
- Yes Serious outcome flagged by Orca1 signal analytics
- Disability, Hospitalization, Required Intervention Outcome categories reported
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FAERS manufacturer and drug safety profiles
Manufacturer drug profiles aggregate the FAERS reports that one manufacturer sent to the FDA naming the drug as a suspect product, so the same drug can be compared across manufacturers. Reaction terms are counted but not listed here; reports are unverified and do not by themselves establish causation.
Source: U.S. Food and Drug Administration (FDA), FAERS public data; aggregation by Orca1